Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset

OBJECTIVES: The clinical benefit of conventional disease-modifying antirheumatic drugs (cDMARDs) for treating ankylosing spondylitis (AS) is generally limited to improvements in peripheral arthritis. However, cDMARDs could be conditionally considered as alternatives to established drugs for improvin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Musculoskelet Dis
Main Authors: Lee, Tae-Han, Koo, Bon San, Nam, Bora, Oh, Ji Seon, Park, Seo Young, Lee, Seunghun, Joo, Kyung Bin, Kim, Tae-Hwan
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705797/
https://ncbi.nlm.nih.gov/pubmed/33294039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20975912
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares